Jinbei oral liquid for idiopathic pulmonary fibrosis: a randomized placebo-controlled trial.

Sci Rep · 2025 · PMC11759330 · PMID 39849152

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The rates of FVC % predicted, FVC, DLCO % predicted, and PaO 2 in the group treatment with JBOL were numerically lower than those in the placebo treatment group, although these differences did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.